Cargando…
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (ST...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306259/ https://www.ncbi.nlm.nih.gov/pubmed/35866437 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.29.2100930 |
_version_ | 1784752507254210560 |
---|---|
author | Simões, Daniel Ehsani, Soudeh Stanojevic, Maja Shubladze, Natalia Kalmambetova, Gulmira Paredes, Roger Cirillo, Daniela Maria Avellon, Ana Felker, Irina Maurer, Florian P Yedilbayev, Askar Drobniewski, Francis Vojnov, Lara Johansen, Anne S Seguy, Nicole Dara, Masoud |
author_facet | Simões, Daniel Ehsani, Soudeh Stanojevic, Maja Shubladze, Natalia Kalmambetova, Gulmira Paredes, Roger Cirillo, Daniela Maria Avellon, Ana Felker, Irina Maurer, Florian P Yedilbayev, Askar Drobniewski, Francis Vojnov, Lara Johansen, Anne S Seguy, Nicole Dara, Masoud |
author_sort | Simões, Daniel |
collection | PubMed |
description | Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (STI). However, in many countries, diagnosis and monitoring, as well as disease response programs, still operate as vertical systems, potentially causing delay in diagnosis and burden to patients and preventing the optimal use of available resources. With countries facing both human and financial resource constraints, during the COVID-19 pandemic even more than before, it is important that available resources are used as efficiently as possible, potential synergies are leveraged to maximise benefit for patients, continued provision of essential health services is ensured. For the infectious diseases, TB, HIV, hepatitis C (HCV) and STI, sharing devices and integrated services starting with rapid, quality-assured, and complete diagnostic services is beneficial for the continued development of adequate, efficient and effective treatment strategies. Here we explore the current and future potential (as well as some concerns), importance, implications and necessary implementation steps for the use of platforms for multi-disease testing for TB, HIV, HCV, STI and potentially other infectious diseases, including emerging pathogens, using the example of the COVID-19 pandemic. |
format | Online Article Text |
id | pubmed-9306259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-93062592022-08-01 Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond Simões, Daniel Ehsani, Soudeh Stanojevic, Maja Shubladze, Natalia Kalmambetova, Gulmira Paredes, Roger Cirillo, Daniela Maria Avellon, Ana Felker, Irina Maurer, Florian P Yedilbayev, Askar Drobniewski, Francis Vojnov, Lara Johansen, Anne S Seguy, Nicole Dara, Masoud Euro Surveill Perspective Technical advances in diagnostic techniques have permitted the possibility of multi-disease-based approaches for diagnosis and treatment monitoring of several infectious diseases, including tuberculosis (TB), human immunodeficiency virus (HIV), viral hepatitis and sexually transmitted infections (STI). However, in many countries, diagnosis and monitoring, as well as disease response programs, still operate as vertical systems, potentially causing delay in diagnosis and burden to patients and preventing the optimal use of available resources. With countries facing both human and financial resource constraints, during the COVID-19 pandemic even more than before, it is important that available resources are used as efficiently as possible, potential synergies are leveraged to maximise benefit for patients, continued provision of essential health services is ensured. For the infectious diseases, TB, HIV, hepatitis C (HCV) and STI, sharing devices and integrated services starting with rapid, quality-assured, and complete diagnostic services is beneficial for the continued development of adequate, efficient and effective treatment strategies. Here we explore the current and future potential (as well as some concerns), importance, implications and necessary implementation steps for the use of platforms for multi-disease testing for TB, HIV, HCV, STI and potentially other infectious diseases, including emerging pathogens, using the example of the COVID-19 pandemic. European Centre for Disease Prevention and Control (ECDC) 2022-07-21 /pmc/articles/PMC9306259/ /pubmed/35866437 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.29.2100930 Text en This article is copyright of the authors or their affiliated institutions, 2022. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Perspective Simões, Daniel Ehsani, Soudeh Stanojevic, Maja Shubladze, Natalia Kalmambetova, Gulmira Paredes, Roger Cirillo, Daniela Maria Avellon, Ana Felker, Irina Maurer, Florian P Yedilbayev, Askar Drobniewski, Francis Vojnov, Lara Johansen, Anne S Seguy, Nicole Dara, Masoud Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond |
title | Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond |
title_full | Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond |
title_fullStr | Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond |
title_full_unstemmed | Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond |
title_short | Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond |
title_sort | integrated use of laboratory services for multiple infectious diseases in the who european region during the covid-19 pandemic and beyond |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306259/ https://www.ncbi.nlm.nih.gov/pubmed/35866437 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.29.2100930 |
work_keys_str_mv | AT simoesdaniel integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT ehsanisoudeh integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT stanojevicmaja integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT shubladzenatalia integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT kalmambetovagulmira integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT paredesroger integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT cirillodanielamaria integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT avellonana integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT felkeririna integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT maurerflorianp integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT yedilbayevaskar integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT drobniewskifrancis integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT vojnovlara integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT johansenannes integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT seguynicole integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT daramasoud integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond AT integrateduseoflaboratoryservicesformultipleinfectiousdiseasesinthewhoeuropeanregionduringthecovid19pandemicandbeyond |